Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
|Active Ingredients:||Caffeine 65mg
|Dosage Form:||Film coated tablet|
|New Zealand Sponsor:||GlaxoSmithKline Consumer Healthcare New Zealand ULC|
|Manufacturer:||GlaxoSmithKline Dungarvan Limited, Dungarvan, Ireland|
|Active Ingredient:||Natalizumab 20mg/mL|
|Dosage Form:||Solution for infusion|
|New Zealand Sponsor:||Biogen NZ Biopharma Limited|
|Manufacturer:||Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany|
Dated this 4th day of May 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).